Susceptibility of klebsiella spp. to tigecycline and other selected antibiotics

Medical Science Monitor

Volumn 16, Issue 6, 2010, Pages

  Sȩkowska, Alicja ^a   Gospodarek, Eugenia ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Extended spectrum beta lactamases; Klebsiella spp; Tigecycline

Indexed keywords

AMIKACIN; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; MINOCYCLINE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISEASE PREDISPOSITION; DISK DIFFUSION; DRUG ACTIVITY; EPSILOMETER TEST; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; KLEBSIELLA; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 80054019681     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Čekanová L, Kolář M, Chromá M et al: Prevalence of ESBL-positive bacteria in the community in the Czech Republic. Med Sci Monit, 2009; 15(7): BR202-6
2. Podschun R, Ullmann U: Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev, 1998; 11: 589-603
3. Stürenburg E, Mack D: Extended-spectrum b-lactamases: implications for the clinical microbiology laboratory, therapy and infection control. J Infect, 2003; 47: 273-95
4. Bradford PA, Weaver-Sands DT, Petersen PJ: In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. Clin Infect Dis, 2005; 41: S315-32
5. Michalska K, Tyski S: New antibiotics applied in skin and subcutaneous tissue infections [Nowe antybiotyki stosowane w zakażeniach skóry i tkanki podskórnej (SSTIS)]. Zakażenia, 2007; 7: 26-35
6. Gniadkowski M, Zabicka D, Hryniewicz W: Recommendations for selecting tests to determine bacterial sensitivity to antibiotic and chemotherapeutics 2009. Determining the sensitivity of Gram-negative rods [Rekomendacje doboru testów do oznaczania wrażliwości bakterii na antybiotyki i chemioterapeutyki 2009. Oznaczanie wrażliwości pałeczek Gram-ujemnych]. Krajowy Ośrodek ds. Lekowrażliwości Drobnoustrojów; 2009
7. Sachs L: Applied statistics. Springer-Verlag, Berlin-Heidelberg, 1984
8. Nijssen S, Florijn A, Bonten MJM et al: Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrobial Agents, 2004; 24: 585-91
9. Kolár M, Látal T, Cermák P et al: Prevalence of ESBL-positive strains of Klebsiella pneumoniae in the Czech Republic and their molecular biology analysis. Klin Mikrobiol Infekc Lek, 2005; 11: 92-99
10. Navon-Venezia S, Hammer-Munz O, Schwartz D et al: Occurrence and phenotypic characteristics of extended-spectrum b-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clin Microbiol, 2003; 41: 155-58
11. Morosini MI, Garcia-Castilio M, Coque TM et al: Antibiotic coresistance in extended-spectrum b-lactamase producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother, 2006; 50: 2695-99
12. Kiffer C, Hsiung A, Oplustil C et al: Antimicrobial susceptibility of Gramnegative bacteria in Brazilian Hospitals: The MYSTIC Program Brazil 2003. Braz J Infect Dis, 2003; 9: 216-24
13. Souli M, Kontopidou FV, Koratzanis E et al: In vitro activity of tigecycline against multiple-drug-resistant including pan-resistant Gram-negative and Gram-positive clinical isolates from Greek hospitals. Antimicrob Agents Chemother, 2006; 50: 3166-69
14. Waites KB, Duffy LB, Dowzicky MJ: Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline an new glycylcycline antimicrobial. Antimicrob Agents Chemother, 2006; 50: 3479-84
15. Ruzin A, Keeney D, Bradford PA: AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob Agents Chemother, 2005; 49: 791-93